MetaOptics Provides Year-End Business Review and Update
SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") As we approach the Christmas festive season and the close of 2025, MetaOptics would like to...
Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U.S. FDA Approval of LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
SHANGHAI, Dec. 17, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Execution of Additional Financing Agreement for Rooftop Solar Power Project in Singapore
TOKYO, Dec. 17, 2025 /PRNewswire/ -- Tokyo Electric Power Company Holdings, Inc. (hereinafter "TEPCO HD") is pleased to announce that, on December 4, 2025, a Special Purpose Vehicle (hereinafter "SPV") jointly established by TEPCO HD and ESR Group...
Carrier Announces Agreement to Sell Riello to Ariston Group
PALM BEACH GARDENS, Fla., Dec. 17, 2025 /PRNewswire/ -- Carrier Global Corporation (NYSE: CARR), global leader in intelligent climate and energy solutions, today announced that it has entered into a definitive agreement to sell its Riello business...
Youlife Group Inc. Announces Non-Binding Letter of Intent as It explores Strategic Expansion in China's Blue-Collar Service Market
BEIJING, Dec. 12, 2025 /PRNewswire/ -- Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, today announced that it has entered into a non-binding letter of intent (the "LOI"),...
Yum China Announces US$460 Million Share Repurchase Agreements for First Half of 2026 as Part of US$1.5 Billion Full-Year Capital Return Plan
SHANGHAI, Dec. 12, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that it has entered into share repurchase agreements in the U.S. and Hong Kong for an aggregate repurchase amount...
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveraging Everest's existing commercial organization - Exclusive Greater China license to develop and...
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao Pharma"), Shanghai Fosun Pharmaceutical Industrial Development Company...
HKEX Expands Index Business with Launch of HKEX Tech 100 Index
New index tracks 100 companies listed in Hong Kong across six major technology-focused themes HKEX's first Hong Kong equity index, marking a significant milestone in Group's index and data business development HKEX enters licensing agreement with E...
AMTD Digital's Subsidiary TGE Executed SPA Successfully to Acquire 50% in The Ritz Carlton Hotel Perth, Australia with a Total Value at A$280 Million
PARIS and NEW YORK and LONDON, Dec. 8, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), and The Generation Essentials Group ("TGE" or the "Purchaser", NYSE: TGE), a subsidiary of AMTD Digital Inc. (NYSE:...